Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 6/20 | 0.49 |
| ▸ | TP53 | P04637 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21274321 | 0.83 | KDM4E (0.50) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| Hydrochloric Acid SCHEMBL29042408 | 0.83 | KDM4E (0.61) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL29484714 | 0.81 | KDM4E (0.63) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL31473547 | 0.81 | KDM4E (0.63) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL31607260 | 0.81 | KDM4E (0.63) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL57525 | 0.81 | KDM4E (0.63) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL31612679 | 0.81 | KDM4E (0.55) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL8343475 | 0.81 | KDM4E (0.55) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL20237398 | 0.79 | KDM4E (0.61) | KDM4ESMN1; SMN2MAPTLMNATDP1 | |
| SCHEMBL30302967 | 0.79 | KDM4E (0.61) | KDM4ESMN1; SMN2MAPTLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5631264-A | NEUROLOGICAL DISORDERS | SANOFI WINTHROP, INC. (US) | 1997-05-20 | — | — | US | disclosed |
| US-5554620-A | Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof | STERLING WINTHROP INC. (US) | 1996-09-10 | — | — | US | disclosed |
| US-5455248-A | Treatment or prevention of neurodegenerative disorders or neurotoxic injuries; binding to PCP receptors | STERLING WINTHROP INC. (US) | 1995-10-03 | — | — | US | disclosed |
| US-5434159-A | Neurodegenerative disorders | STERLING WINTHROP INC. (US) | 1995-07-18 | — | — | US | disclosed |
| US-5430036-A | Neurodegenerative disorders, neurotoxic injuries | STERLING WINTHROP INC. (US) | 1995-07-04 | — | — | US | disclosed |
| EP-0656359-A1 | Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof | STERLING WINTHROP INC. (US) | 1995-06-07 | — | — | EP | disclosed |
| EP-0648769-A1 | 12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1995-04-19 | — | — | EP | disclosed |
| US-5380729-A | Treatment or prevention of neurodegenerative disorders or neurotoxic injuries | STERLING WINTHROP INC. (US) | 1995-01-10 | — | — | US | disclosed |